07.21.26 -- How To Match CGT Manufacturing Models To Pipeline Needs

Packaging plays a critical role in ensuring the stability, safety, and efficacy of viral vector-based gene therapies. Key considerations include container closure integrity, low chemical reactivity, minimal extractables and leachables, reduced surface adsorption, and particulate control, particularly during ultra-low-temperature storage. Cyclic Olefin Polymer (COP) CZ vials address these challenges through high inertness, robust integrity, and compatibility with modern fill-finish processes, making them a reliable containment solution for advanced gene therapy products.

This session shows how integrated governance and real‑time data boost visibility, collaboration, and control in outsourced gene therapy development.

Safely remove the bead removal kit from this magnetic cell separation system. This video details the process to remove the cassette and fluid lines.

How long can you store frozen stem cells? Receive expert advice on the long-term storage and cryopreservation of stem cells and stem-cell derived therapies.

The streamlined AAV transient transfection platform de-risks your path to IND and reduces complexity and timeline for lengthy process and analytical development.

Learn how electroporation technology improves gene editing efficiency, reduces cell death, and enables scalable workflows for cell therapy, screening, and bioproduction in this informative webinar.

This opening segment of Cell & Gene Live, How CGT Developers Can Choose the Right Manufacturing Model for Their Pipeline, features Omkar Kawalekar, Ph.D., Manufacturing & Supply Chain Lead, Deloitte Consulting and Zoe Zheng, Executive Director, Pipeline Technical and Strategic Lead, Legend Biotech discussing how early manufacturing decisions shape scalability and commercialization.